Deal Making and Product Development in Europe: Changes and Trends You Need to Know About
Everyone knows that life sciences product development has become a global enterprise. We find, however, that too many companies continue to stay abreast of only US regulation, or only EU regulation. Biopharmaceutical companies at every stage of product development need to follow closely developments on both sides of the Atlantic. Why? Because EU regulation is changing constantly and in significant ways, and it influences - or should influence - the way deals are done.
This seminar will highlight why keeping up with EU developments is crucial, and will bring you up to date on some important issues affecting research, licensing, partnering, product acquisition and private company mergers and acquisitions. This seminar will be particularly useful for in-house legal, regulatory and business development officers who are involved in development of products and European investments, licenses and acquisitions.
Topics will include:
- New European pharmaceutical legislation - how will it change deals?
- How to benefit from transatlantic information sharing
- Impact of the EU Clinical Trials Directive on product development
- New pediatric requirements: compliance and incentives
- What is driving current trends in M&A: Key issues to watch for when documenting the acquisition of businesses in the EU
The discussion will be led by Lincoln Tsang, Amanda Wearing and Jeremy Willcocks, each of our London office, and will be moderated by Steve Parker, of our Virginia office.
- Deal Making and Product Development in Europe: Changes and Trends You Need to Know About
The Changing European Regulatory Landscape, Lincoln Tsang - appeared in the 2004 issue of International Journal of Pharmaceutical Medicine.
Medicines for Children II, Ian Dodds-Smith and Lincoln Tsang - appeared in the August/September 2004 issue of Life Sciences Law & Business.
Medicines For Children, Lincoln Tsang and Ian Dodds-Smith - appeared in the June/July 2004 issue of Life Sciences Law & Business.
Two Mouths, If Not One Voice, Ludger Wess, appeared in the October 18, 2004 issue of BioCentury.
Please let us know if you are interested in receiving CLE credit.
If you or someone from your organization plans to attend in person or by phone, please call the Arnold & Porter events line at (703)720-7111 or respond by e-mail to Dorothy_Woods@aporter.com. The phone number for call-in participants will be provided upon request. If you have any questions, please call Dorothy at (703)720-7129.